John Overdeck’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-142,880
Closed -$7.29M 3586
2024
Q4
$7.29M Sell
142,880
-98,458
-41% -$4.84M 0.02% 896
2024
Q3
$9.95M Buy
241,338
+161,852
+204% +$7.77M 0.02% 761
2024
Q2
$3.83M Buy
79,486
+53,456
+205% +$2.37M 0.01% 1138
2024
Q1
$1.25M Sell
26,030
-45,314
-64% -$2.42M ﹤0.01% 1805
2023
Q4
$4.63M Sell
71,344
-195,171
-73% -$11.8M 0.01% 1035
2023
Q3
$17.4M Buy
266,515
+71,279
+37% +$4.48M 0.05% 425
2023
Q2
$11.4M Buy
195,236
+45,013
+30% +$2.84M 0.03% 588
2023
Q1
$9.27M Buy
150,223
+144,123
+2,363% +$8.65M 0.03% 615
2022
Q4
$388K Buy
+6,100
New +$442K ﹤0.01% 2130
2022
Q2
Sell
-42,508
Closed -$3.85M 3029
2022
Q1
$3.85M Buy
+42,508
New +$3.48M 0.01% 1042
2020
Q3
Sell
-15,358
Closed -$744K 3648
2020
Q2
$744K Buy
+15,358
New +$733K ﹤0.01% 1729

Other funds holding NARI

John Overdeck's NARI Position: Q1 2025 in Review

John Overdeck sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 142,880 shares — an estimated $7.29M sold.

John Overdeck first reported a position in NARI in Q2 2020 and held it in 11 quarters. The position peaked at $17.4M in Q3 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • John Overdeck reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • John Overdeck sold 142,880 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $7.29M.
  • John Overdeck first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • John Overdeck's Inari Medical, Inc. Common Stock position peaked at $17.4M in Q3 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.